Report

Patient advocates and some experts raise alarm over perceived risks of a Neurocrine drug

STAT reports that the concerns involve a rare disease drug sold by Neurocrine Biosciences.

1 Source, 1h ago, first seen 1h ago

TLDR

STAT reports growing alarm among patient advocates and some experts over the perceived risks of a rare disease drug sold by Neurocrine Biosciences.

Today's Rank

—

1 Source, first seen 1h ago

— likes— comments— saves— reposts

Positive——Negative

Not enough discussion yet.

No sentiment analysis available yet.

Featured Source